Cingulate Inc. (NASDAQ:CINGW) Short Interest Update

Cingulate Inc. (NASDAQ:CINGW) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 1,819 shares, an increase of 127.4% from the December 15th total of 800 shares. Based on an average trading volume of 26,172 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 26,172 shares, the days-to-cover ratio is currently 0.1 days.

Cingulate Stock Down 0.4%

CINGW stock opened at $0.08 on Wednesday. Cingulate has a 12 month low of $0.02 and a 12 month high of $0.18. The company has a 50-day moving average price of $0.05 and a 200 day moving average price of $0.06.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.